Nkarta Therapeutics

Developer of cell therapies for the treatment of cancer

placeSan Francisco, California, United States calendar_todayFounded 2015 groups163 employees language nkartatx.com

Registered entities

Social engagement

Social engagement: 14.8K social following, 10 posts in the last 12 months — below the industry typical range.

Investor mix

12 investors on record; lead investors include Samsara BioCapital; 1 has since exited.

Investor typeCountShare
Venture capital433%
Private equity217%
Bank & private debt217%
Other / undisclosed433%

Recent activity

10 Jun 2026
Event
EULAR - European Alliance of Associations for Rheumatology 2026 Congress
1 Jun 2026
Event
CAR-NK investigatory product webinar on natural killer cells in myositis
Coming soon